Astonea Labs

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0TG901011
  • NSEID:
  • BSEID: 544409
INR
333.00
0.55 (0.17%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 1000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 51.34% vs 21.61% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -11.67% vs 26.95% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -10.76% vs 23.53% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -15.61% vs 31.46% in Mar 2025

Compare Profit and Loss Results of Astonea Labs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
147.00
136.00
11.00
8.09%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
147.00
136.00
11.00
8.09%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
1.00
-5.00
-500.00%
Raw Materials Consumed
102.00
107.00
-5.00
-4.67%
Power & Fuel Cost
1.00
1.00
0.00
0.00%
Employee Cost
7.00
5.00
2.00
40.00%
Operating Expenses
5.00
0.00
5.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
0.00
2.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
134.00
121.00
13.00
10.74%
Operating Profit (PBDIT) excl Other Income
13.00
15.00
-2.00
-13.33%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
13.00
17.00
-4.00
-23.53%
Interest
3.00
2.00
1.00
50.00%
Profit before Depriciation and Tax
10.00
14.00
-4.00
-28.57%
Depreciation
4.00
2.00
2.00
100.00%
Profit Before Taxation & Exceptional Items
5.00
11.00
-6.00
-54.55%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
11.00
-6.00
-54.55%
Provision for Tax
1.00
3.00
-2.00
-66.67%
Profit After Tax
4.00
8.00
-4.00
-50.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
9.00
27.00
-18.00
-66.67%
Profit Available for appropriations
14.00
36.00
-22.00
-61.11%
Appropriations
14.00
36.00
-22.00
-61.11%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.49
5.82
-1.33
-22.85%
Profit And Loss - Net Sales
Net Sales 147.58 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 51.34% vs 21.61% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.35 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -11.67% vs 26.95% in Mar 2025

Profit And Loss - Interest
Interest 3.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -10.76% vs 23.53% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 4.52 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -15.61% vs 31.46% in Mar 2025

Footer loading